Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 11Phase 1/2 8Phase 1 6Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 4Squamous Cell Carcinoma of Head and Neck 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasms 2Lymphoproliferative Disorders 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Melanoma 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Extensive Stage Lung Small Cell Carcinoma 1Endometrial Neoplasms 1Carcinoma 1Advanced Solid Tumor 1

Interventions

Topotecan 2Drug Therapy 2sintilimab 1dinutuximab 1atezolizumab 1Temozolomide 1SR 48692 1Rabeprazole 1Irinotecan 1Etoposide 1Electroporation 1EC regimen 1E-3810 1Cryosurgery 1Carboplatin 1Bevacizumab 12,2',4,4',5-pentachlorodiphenyl ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Small Cell Lung Carcinoma × atezolizumab × Clear all
NCT07226999 2026-06-04

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Pfizer

Phase 2/3 Recruiting
550 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡